Corporate Office HQ

Health

Hologic Corporate Office

Hologic Corporate produces diagnostic and medical imaging systems related to women’s health. The company was founded in 1985 in Massachusetts.

Hologic operates through four divisions: surgical health, breast health, skeletal health, and diagnostics. The company’s major brands include Lorad, Fluoroscan, NovaSure, MyoSure, Selenia, Discovery, and Multicare.

Popular products include c-arm imaging systems to guide doctors during orthopedic surgery, ThinPrep Pap test for cervical cancer screening, and products that treat excessive uterine bleeding.

In 2012 Hologic merged with Gen-Probe in a $3.7 billion deal. The company has a strategic partnership with Quest Diagnostics Incorporated.

Hologic trades publicly on the NASDAQ under the ticker symbol HOLX, is a member of the S&P 400, is #841 in the Fortune 1000, has 5,351 employees, and had $2.55 billion in revenue in 2014.

Hologic Corporation

Hologic Corporate produces diagnostic and medical imaging systems related to women’s health. The company was founded in 1985 in Massachusetts.

Hologic operates through four divisions: surgical health, breast health, skeletal health, and diagnostics. The company’s major brands include Lorad, Fluoroscan, NovaSure, MyoSure, Selenia, Discovery, and Multicare.

Popular products include c-arm imaging systems to guide doctors during orthopedic surgery, ThinPrep Pap test for cervical cancer screening, and products that treat excessive uterine bleeding.

History

In 2012 Hologic merged with Gen-Probe in a $3.7 billion deal. The company has a strategic partnership with Quest Diagnostics Incorporated.

Hologic trades publicly on the NASDAQ under the ticker symbol HOLX, is a member of the S&P 400, is #841 in the Fortune 1000, has 5,351 employees, and had $2.55 billion in revenue in 2014.

AptarGroup Corporate Office

AptarGroup makes pump dispensers for food, fragrances, cosmetics, pharmaceuticals, and other personal care items. The company also produces dispensing closures for squeezable containers for toiletries and aerosol valves.

The company’s product lines are sold under the producing subsidiary brands, including Emsar, Pfeiffer, Seaquist, and Valois.

AptarGroup trades publicly on the New York Stock Exchange under the ticker symbol ATR, is a member of the S&P 400, is #830 in the Fortune 1000, has 13,000 employees, and had $2.60 billion in revenue in 2014.

AptarGroup

AptarGroup makes pump dispensers for food, fragrances, cosmetics, pharmaceuticals, and other personal care items. The company also produces dispensing closures for squeezable containers for toiletries and aerosol valves.

The company’s product lines are sold under the producing subsidiary brands, including Emsar, Pfeiffer, Seaquist, and Valois.

AptarGroup trades publicly on the New York Stock Exchange under the ticker symbol ATR, is a member of the S&P 400, is #830 in the Fortune 1000, has 13,000 employees, and had $2.60 billion in revenue in 2014.

History

IMS Health Incorporated Corporate Office

IMS Health Incorporated was founded in 1954 by Bill Frohlich and Davd Dubow as Intercontinental Marketing Services.

The company provides market research and sales management to its clients in the healthcare and pharmaceutical industries, collecting healthcare information, de-identifying it, and selling it to clients to be used in commercialization plans, to measure the effectiveness of advertising and marketing, and to select patient populations for specific therapies.

IMS Health Incorporated trades publicly on the New York Stock Exchange under the ticker symbol IMS, is #825 in the Fortune 1000, has 10,200 employees, and had $2.64 billion in revenue in 2014.

IMS Health Incorporated

IMS Health Incorporated was founded in 1954 by Bill Frohlich and Davd Dubow as Intercontinental Marketing Services.

The company provides market research and sales management to its clients in the healthcare and pharmaceutical industries, collecting healthcare information, de-identifying it, and selling it to clients to be used in commercialization plans, to measure the effectiveness of advertising and marketing, and to select patient populations for specific therapies.

IMS Health Incorporated trades publicly on the New York Stock Exchange under the ticker symbol IMS, is #825 in the Fortune 1000, has 10,200 employees, and had $2.64 billion in revenue in 2014.

History

Covance Corporate Office

Covance was founded in 1968 as Environmental Sciences Corporation in Seattle, Washington.

In 1972 the company bought Hazleton Laboratories, a laboratory that conducted toxicology testing, and took on that name. By 1982, Hazleton had become the largest biological testing company in the U.S.

Covance was purchased by Labcorp in 2014 in a $6.1 billion deal.

Today the company provides testing services, including toxicology studies and biostatistical analysis for pharmaceutical and biotech companies. Other clients include companies in the food, agrochemical, and chemical industries. The company also provides testing services which include designing and realizing human clinical trials.

Covance

Covance was founded in 1968 as Environmental Sciences Corporation in Seattle, Washington.

In 1972 the company bought Hazleton Laboratories, a laboratory that conducted toxicology testing, and took on that name. By 1982, Hazleton had become the largest biological testing company in the U.S.

Covance was purchased by Labcorp in 2014 in a $6.1 billion deal.

History

Today the company provides testing services, including toxicology studies and biostatistical analysis for pharmaceutical and biotech companies. Other clients include companies in the food, agrochemical, and chemical industries. The company also provides testing services which include designing and realizing human clinical trials.

Endo Pharmaceuticals Corporate Office

Endo Pharmaceuticals was created in 1997 by a management buyout at DuPont Merck. At that time, the CEO, Executive Vice President of Operations, and another colleague purchased Endo Laboratories’ 12 brand products including Percoset, Percodan, and Opana, as well as the company’s generic products.

The company began to trade publicly when it acquired Algos Pharmaceutical in 2000.

Endo expanded into Canada in 2014, creating Endo Internacional plc. At the same time, the company established new global headquarters in Dublin.

Endo Pharmaceuticals trades publicly on the NASDAQ under the ticker symbol ENDP, is a member of the S&P 500, is #766 in the Fortune 1000, has 3,371 employees, and had $2.66 billion in revenue in 2014.

Endo Pharmaceuticals

Endo Pharmaceuticals was created in 1997 by a management buyout at DuPont Merck. At that time, the CEO, Executive Vice President of Operations, and another colleague purchased Endo Laboratories’ 12 brand products including Percoset, Percodan, and Opana, as well as the company’s generic products.

The company began to trade publicly when it acquired Algos Pharmaceutical in 2000.

Endo expanded into Canada in 2014, creating Endo Internacional plc. At the same time, the company established new global headquarters in Dublin.

History

Endo Pharmaceuticals trades publicly on the NASDAQ under the ticker symbol ENDP, is a member of the S&P 500, is #766 in the Fortune 1000, has 3,371 employees, and had $2.66 billion in revenue in 2014.